Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis

Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis

Background The topical corticosteroid halobetasol propionate (HP) and retinoid tazarotene (TAZ) are effective in psoriasis treatment. Fixed-combination HP 0.01%/TAZ 0.045% lotion has demonstrated efficacy and safety in moderate-to-severe plaque psoriasis. Objective To investigate the maintenance of...

Full description

Bibliographic Details
Main Authors: Mark G. Lebwohl, Linda Stein Gold, James Q. Del Rosso, Lawrence Green, Abby Jacobson
Format: Article
Language:English
Published: Taylor & Francis Group 2022-05-01
Series:Journal of Dermatological Treatment
Subjects:
topical
psoriasis
maintenance
Online Access:http://dx.doi.org/10.1080/09546634.2021.1914310

Internet

http://dx.doi.org/10.1080/09546634.2021.1914310

Similar Items